Pediatric brain cancer predictions are becoming increasingly sophisticated thanks to breakthroughs in artificial intelligence (AI) technologies.Modern research showcases that AI tools are significantly enhancing the accuracy of relapse risk assessments for children diagnosed with gliomas, a common type of brain tumor.